6 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... here is a quick overview ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... /ambcarerx #CHF ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... 19 - Zika virus ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... may precede the neurologic ... Electrolyte abnormality, Medication ... Syndrome #diagnosis #management ... #neurology
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
Transverse Myelitis Overview ... Herpes simplex virus ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management ... #neurology #differential